Comparative treatment patterns, healthcare resource utilization and costs of atomoxetine and long-acting methylphenidate among children and adolescents with attention-deficit/hyperactivity disorder in Germany
Details
The content you want is available to Zendy users.Already have an account? Click here. to sign in.